EP 0544900 A4 19931201 - TRANSDERMAL NICOTINE ABSORPTION DOSAGE UNIT AND PROCESS
Title (en)
TRANSDERMAL NICOTINE ABSORPTION DOSAGE UNIT AND PROCESS
Publication
Application
Priority
US 72112991 A 19910626
Abstract (en)
[origin: WO9300057A1] Provided by this invention is a transdermal dosage unit for administering nicotine for reducing the desire or craving for smoking tobacco. The dosage unit reduces or substantially eliminates the reddening of the skin at the site of the nicotine absorption commonly associated with transdermal absorption of nicotine. Also, provided is a dosage unit which has present an agent for increasing skin wearability of the transdermal dosage unit. Additionally, provided is a method for reducing the desire or craving of a subject for smoking tobacco by use of the provided transdermal dosage unit.
IPC 1-7
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61K 31/465 (2006.01); A61K 47/14 (2006.01)
CPC (source: EP)
A61K 9/0014 (2013.01); A61K 9/7061 (2013.01); A61K 31/465 (2013.01); A61K 47/14 (2013.01)
Citation (search report)
- [XP] EP 0464573 A1 19920108 - LOHMANN THERAPIE SYST LTS [DE]
- [X] US 4908213 A 19900313 - GOVIL SHARAD K [US], et al
- [Y] US 4844903 A 19890704 - SETH PAWAN [CH]
- See references of WO 9300057A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
DOCDB simple family (publication)
WO 9300057 A1 19930107; AU 2294192 A 19930125; CA 2094913 A1 19921227; CN 1067811 A 19930113; EP 0544900 A1 19930609; EP 0544900 A4 19931201; TW 221970 B 19940401
DOCDB simple family (application)
US 9205271 W 19920624; AU 2294192 A 19920624; CA 2094913 A 19920624; CN 92105287 A 19920626; EP 92915353 A 19920624; TW 81104426 A 19920604